Article

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.

2022-08-24

Abstract excerpt

<h4>Background: </h4> Since the outbreak of the novel Coronavirus in Wuhan and its transformation into a global pandemic, the main concern of medical systems has been to find vaccines to help the immune system overcome the virus or, at the very least, to prevent COVID-19 positive cases from deteriorating into serious conditions necessitating hospitalization. The pace of COVID-19 vaccine production accelerated, res...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b019ea95-4fdf-5e55-96f8-7bcca3bf6aff
DOI: 10.14293/s2199-1006.1.sor-.ppoo5f5.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Review on different COVID-19 vaccines approved for Emergency Use Listing by WHO until 11 July 2022: characterization, pharmacological properties, mechanism of action and adverse events.DOI 10.14293/s2199-1006.1.sor-.ppoo5f5.v1Read

A comprehensive review on efficient approaches for combating coronaviruses.Semantic proximity Read

An objective systematic comparison of the most common adverse events of COVID-19 vaccinesSemantic proximity Read

Effectiveness of COVID‑19 vaccines and their challenges (Review)Semantic proximity Read

A 6-week time period may not be sufficient to identify potential adverse events following COVID-19 vaccinationSemantic proximity Read

COVID-19 and COVID-19 Vaccine in Japan—A Review from a General Physician's PerspectiveSemantic proximity Read

Vaccines platforms and COVID-19: what you need to knowSemantic proximity Read

A systematic review of COVID-19 vaccine efficacy and effectiveness against SARS-CoV-2 infection and diseaseSemantic proximity Read

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from GreeceSemantic proximity Read

Serious adverse events reported from the COVID-19 vaccines: A descriptive study based on WHO databaseSemantic proximity Read

Effectiveness of the WHO-authorized Covid-19 Vaccines: a Rapid Review of Global Reports till June 30, 2021Semantic proximity Read

Efficacy and Safety of an Inactivated Whole-Virion SARS-CoV-2 Vaccine (CoronaVac) in Brazilian Healthcare Professionals: The PROFISCOV TrialSemantic proximity Read